focus -WSS

focus

author：focus 2025-09-29 01:36:59 - browse：7877

A crowd of miniature figurines facing towards an hourglass. -- cancer coverage from STAT — Adobe

It’s no secret that a lucky few seem to glide into old age, the years settling gracefully on their bodies, while others appear to have been dragged through time tied to a metaphorical garbage truck. Biologists have been developing numerous ways to measure the rate an individual ages — often called an accelerated or decelerated “biological age” — and trying to translate it into a heightened or reduced risk of the morbidity and mortality that comes with aging.

There’s been a proliferation of various biological aging clocks, mathematical models that look at things like genetic markers or proteins in your body to make some estimation of an individual’s biological age. Research interest in using these clocks has exploded. In the last five years, thousands of papers on or incorporating the clocks have been published. The paper describing one popular biological aging clock, PhenoAge, has over 1,800 citations alone. One recent study suggested that a reason cancer incidence is increasing among younger adults may be accelerated aging, based on this particular clock.

But as scientists use these clocks to associate biological age with specific health risks, like cancer or dementia, and numerous companies eagerly offer biological age measurements in exchange for hundreds of bucks, it may be worth noting that experts don’t agree on what “biological age” actually is.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Questions and answers about ramping up H5N1 bird flu vaccine

WSS

Trump surgeon general acknowledges mistakes during Covid

For longer

Humana sues Biden admin over Medicare Advantage audit rule

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Stem cell treatment guidelines are released by FDA

The (many) problems with a new study criticizing cancer screening

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

What does generative AI mean for health care? We asked experts

Investigation reveals sickle cell patients pressured into sterilizations

Trump demands the U.S. pay no more for drugs than other countries … again

How to fix cancer clinical trials' diversity problem

Tori Bowie and the unacceptable rates of Black maternal death

Cue Health, Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Bright Health sells Medicare Advantage business to Molina

The 10 drugs up first for Medicare price negotiation

hotspot

As a primary care physician, here's how I hope to partner with AI

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Listen: A conversation with researcher Kevin Esvelt on biosecurity

How to fix cancer clinical trials' diversity problem

As a primary care physician, here's how I hope to partner with AI

How to fix cancer clinical trials' diversity problem

hotspot

explore

knowledge

entertainment